Literature DB >> 33821551

Clinical Characteristics and Controllable Risk Factors of Osteoporosis in Elderly Men with Diabetes Mellitus.

Chunling Li1, Shufang Wang2, Mengru Du3, Yihan Wei3, Sheng Jiang3.   

Abstract

OBJECTIVE: To analyze the clinical characteristics and controllable risk factors of osteoporosis in elderly men with type-2 diabetes mellitus (T2DM).
METHODS: A total of 250 elderly OP patients with T2DM were included in the present study. Patients with one or more common chronic diseases (including hypertension, coronary heart disease, heart failure, chronic bronchitis, chronic nephrosis, and cirrhosis), and a course of more than 3 years were defined as complicated with chronic diseases. Blood glucose, cholesterol, triglyceride, low-density lipoprotein, high-density lipoprotein, calcium, phosphorus, glycosylated hemoglobin, urea nitrogen, creatinine, fasting insulin, liver function, and 25-hydroxy vitamin D3 levels were measured. Bone mineral density was also measured.
RESULTS: A total of 16 patients (6.4%) had severe osteoporosis. Furthermore, 66 patients (26.4%) had blood glucose control that reached the standard, while 176 patients (70.4%) used more than two anti-diabetic drugs. The serum testosterone level was lower than the median in 87 patients (34.8%) and in 56 smokers (22.4%). Furthermore, 138 patients (55.2%) were overweight and obese, six patients (2.4%) were underweight, 197 patients (78.8%) had chronic diseases, 88 patients (35.2%) were sticking to exercise, and 117 patients (46.8%) had less exercise. In addition, 92 patients (36.8%) were treated with osteotrophy-protective agents, and 24 patients (9.6%) received anti-osteoporosis therapy. Smoking, poor glycemic control, low testosterone levels, less exercise, and complications with chronic diseases were the most relevant controllable risk factors.
CONCLUSION: For elderly male osteoporosis patients with type-2 diabetes, smoking cessation, blood sugar control up to the standard, regular exercise, active prevention and treatment of complications, and appropriate testosterone supplementation are necessary for preventing and curing osteoporosis.
© 2021 The Authors. Orthopaedic Surgery published by Chinese Orthopaedic Association and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Clinical characteristics; Elderly men; Hazardous factors; Osteoporosis type-2 diabetes

Year:  2021        PMID: 33821551     DOI: 10.1111/os.12957

Source DB:  PubMed          Journal:  Orthop Surg        ISSN: 1757-7853            Impact factor:   2.071


  5 in total

1.  Increased Risk of Temporomandibular Joint Disorder in Osteoporosis Patients: A Longitudinal Study.

Authors:  So Young Kim; Dae Myoung Yoo; Mi Jung Kwon; Ji Hee Kim; Joo-Hee Kim; Soo-Hwan Byun; Bumjung Park; Hyo-Jeong Lee; Hyo Geun Choi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-31       Impact factor: 5.555

2.  Novel nomogram for predicting the 3-year incidence risk of osteoporosis in a Chinese male population.

Authors:  Yaqian Mao; Lizhen Xu; Ting Xue; Jixing Liang; Wei Lin; Junping Wen; Huibin Huang; Liantao Li; Gang Chen
Journal:  Endocr Connect       Date:  2021-09-13       Impact factor: 3.335

3.  Effect of Diabetes Mellitus on Implant Osseointegration of Titanium Screws: An Animal Experimental Study.

Authors:  Lei Xiao; Yi-Juan Zhou; Ya-Bin Jiang; Man Seng Tam; Lek Hang Cheang; Hua-Jun Wang; Zhen-Gang Zha; Xiao-Fei Zheng
Journal:  Orthop Surg       Date:  2022-04-22       Impact factor: 2.279

4.  Effects of testosterone and exercise training on bone microstructure of rats.

Authors:  Catarina Jota-Baptista; Ana I Faustino-Rocha; Margarida Fardilha; Rita Ferreira; Paula A Oliveira; Marta Regueiro-Purriños; José A Rodriguez-Altonaga; José M Gonzalo-Orden; Mário Ginja
Journal:  Vet World       Date:  2022-03-22

Review 5.  Research progress of coumarins and their derivatives in the treatment of diabetes.

Authors:  Yinbo Pan; Teng Liu; Xiaojing Wang; Jie Sun
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.